Oxford Gene Technology at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
Oxford Gene Technology takes part in 1 session at FoG London 2027 in London, and exhibits at Booth 132. Its session reports a retrospective study of next-generation sequencing (NGS) for measuring minimal residual disease in acute myeloid leukaemia (AML) samples. It looks at what a broader genomic view adds to tracking residual disease.
| Organization | FoG London 2027 Attendance |
|---|---|
Oxford Gene Technology Oxford, UK | ◆Agenda Partner |
Maker of hybridisation-based genetic testing products, such as microarrays, FISH probes and NGS panels, for clinical research and diagnostic labs. | Booth Exhibiting at Booth 132 Talk Thu Jan 28 14:40–15:10 MRD Through a Broader Genomic Lens: Findings from a retrospective study of NGS-based MRD analysis in AML sample cohorts How highly sensitive DNA sequencing panels could track leftover leukaemia cells in acute myeloid leukaemia samples to better judge relapse risk. |
Find decision makers at Oxford Gene Technology
Tell us what you sell and we’ll find the people at Oxford Gene Technology most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction